Initia Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.10 M
- Company Age 23 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 26.52%
- Profit Growth -10.33%
- Ebitda -26.29%
- Net Worth 0.90%
- Total Assets -0.42%
About Initia Pharmachem
Initia Pharmachem Private Limited (IPPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 March 2001 and has a history of 23 years and ten months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Axiom Chemicals Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Eknath Kalyanpur and Mangala Kalyanpur serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24117MH2001PTC131344
-
Company No.
131344
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Mar 2001
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Initia Pharmachem?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Eknath Kalyanpur
|
Director | 01-Oct-2011 | Current |
|
Mangala Kalyanpur
|
Director | 22-Mar-2001 | Current |
Financial Performance of Initia Pharmachem.
Initia Pharmachem Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 26.52% increase. The company also saw a substantial fall in profitability, with a 10.33% decrease in profit. The company's net worth moved up by a moderate rise of 0.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Initia Pharmachem?
In 2022, Initia Pharmachem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Bioprosol Private LimitedMangala Kalyanpur is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Initia Pharmachem?
Unlock and access historical data on people associated with Initia Pharmachem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Initia Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Initia Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
